Showing results (11-20 of 74) with videos related to
Sort By:
Pageof 8
Expert Opinion on Drug Metabolism & Toxicology|August 22, 2013
Pharmacokinetic evaluation of pomalidomide for the treatment of myelomaFrancesca Gay, Roberto Mina, Rossella Troia, et al.Clinical Lymphoma, Myeloma & Leukemia|December 3, 2013
Role of consolidation/maintenance therapy in multiple myelomaAntonio Palumbo, Roberto Mina, Chiara Cerrato, et al.Oncotarget|September 27, 2017
Emerging drugs and combinations to treat multiple myelomaAlessandra Larocca, Roberto Mina, Francesca Gay, et al.Expert Opinion on Pharmacotherapy|December 20, 2015
New pharmacotherapy options for multiple myelomaRoberto Mina, Chiara Cerrato, Annalisa Bernardini, et al.Future Oncology (London, England)|November 8, 2012
Current treatment strategies with lenalidomide in multiple myeloma and future perspectivesAlessandra Larocca, Federica Cavallo, Roberto Mina, et al.Leukemia & Lymphoma|November 8, 2016
Plasma cell leukemia: update on biology and therapyRoberto Mina, Mattia D'Agostino, Chiara Cerrato, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Approach to the Older Adult With Multiple MyelomaRoberto Mina, Sara Bringhen, Tanya M Wildes, et al.Expert Opinion on Investigational Drugs|June 7, 2014
Current Phase II investigational proteasome inhibitors for the treatment of multiple myelomaSara Bringhen, Francesca Gay, Francesca Donato, et al.Clinical Lymphoma, Myeloma & Leukemia|January 14, 2025
Multiple Myeloma in Italy: An Epidemiological Model by Treatment Line and Refractoriness StatusRoberto Mina, Silvia Mangiacavalli, Bernardo Rossini, et al.Cancers|October 27, 2022
Advances and Hurdles in CAR T Cell Immune Therapy for Solid TumorsFrancesco Boccalatte, Roberto Mina, Andrea Aroldi, et al.Pageof 8